segment margin gain
trim ep forecast establish
estim per share featur move part
around pension-rel incom tax strong organ growth
point healthi oper momentum come year
also see progress cash gener trade bottom
broker group even produc among best organ growth larg
achiev target price target next year project
ebitda still discount peer figur
report adjust ep ahead
estim slightli street consensu fx
headwind period total revenu billion
line consensu forecast fraction project
billion overal organ growth improv
came despit challeng year-over-year comparison
expans adjust tax rate quarter
estim guidanc incorpor full-year rate
incom million flat versu line
adjust ebitda quarter million compar
estim million street mean million full-
year adjust ebitda margin bp essenti
line manag guidanc bp free cash flow
billion almost doubl result
manag provid initi guidanc
adjust ep includ headwind currenc ep
growth outlook constrain lower level incom
differ per share along uptick full-year tax
rate per share otherwis expect ep growth would
double-digit
free cash flow project increas least annual
next three year attribut end integr spend higher
segment profit lower receiv dso
human capit benefit hcb segment revenu million
exceed forecast million base organ growth
ahead gain immediately-preced third quarter
manag point solid growth across busi line base
increas advisori work specialti product sale north america
tr target
increas global benefit manag appoint
reward oper saw strong demand compens survey
advisori work technolog administr solut retir
modestli latter oper compani saw lower level
de-risk activ higher project volum asia
hcb oper margin year-ago
quarter exceed estim
corpor risk broke crb unit organ revenu advanc improv
last quarter contribut total top-line million estim
million compani gener growth across geographi particular strength north
america advanc strong organ follow great britain western europ
manag point recent cross-sel success integr approach help land
number larg account also indic construct healthi end market
segment oper margin ahead forecast exclud new
revenu standard profit advanc bp year year
organ growth invest risk reinsur irr roughli line
gain manag highlight posit expans across oper includ
reinsur invest insur consult technolog wholesal max matthiessen
somewhat off-set declin underwrit capit manag result
certain divestitur recent quarter
segment oper margin gener keep last year profit
benefit deliveri administr bda gener organ revenu growth
slightli last quarter line assumpt new revenu standard
effect back end-load revenu segment came million though note
forecast million presum issu least part
mis-judg new standard manag report tailwind compani expand client
base new membership enrol across busi
segment oper incom healthi new standard old
standard improv bp year year
manag suggest organ growth outlook bda probabl similar
compani whole perhap mid- single-digit enrol growth remain
healthi deceler somewhat
page
million except per share data
commiss fee
commiss fee
commiss fee
commiss fee
fair valu adjust defer revenu
reimburs expens
salari benefit
interest earn associ net tax
updat
requir disclosur last tab workbook
compani file strh estim
result restat use pro-forma result impact certain line item explicitli restat compani
price
page
advisori brokerag compani offer servic world-wide divid
oper four busi segment corpor risk broke exchang solut
capit benefit invest risk reinsur origin found base
london compani formerli known willi group hold plc chang name
januari acquir tower watson co
buy rate predic opinion compani continu drive margin expans
cost reduct top-lin growth cross-sel well expand health
exchang opportun given uncertainti space also believ compani benefit
short-term tailwind emerg interest cyber secur coverag earli client
win
valuat risk
price target current trade ev ebitda multipl
peer financi out-performance next sever year could result multipl
expans cross-sel potenti view allow outperform
brokerag consult peer new experienc senior leadership team
price target assum stock trade next year ebitda
risk may achiev price target unsuccess integr tower watson
 co also insur price may improv make difficult compani gener
posit organ growth addit tw risk includ declin asset price
could reduc amount pension benefit asset affect health compani client
signific decreas demand consult actuari servic result
chang econom condit factor may also affect stock
mark hugh herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
